|
Use of delta 8 THC to treat inflammatory and autoimmune diseases
Reference #: 01583
The University of South Carolina is offering licensing opportunities for Use of delta 8 THC to treat inflammatory and autoimmune diseases
Background:
There are millions of people who suffer from debilitating inflammatory and autoimmune diseases against which there is no cure. Delta-8 THC is present in small quantity in cannabis...
Published: 6/12/2026
|
Updated: 8/9/2022
|
Inventor(s): Prakash Nagarkatti, Mitzi Nagarkatti, Khadija Kakar
Keywords(s): anti-inflammatory biotech, anti-inflammatory pharma, autoimmune diseases, cannabinoids, inflammation
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
Blood-cytokine levels as adverse outcome predictors following biomaterial implant surgery
Reference #: 01566
The University of South Carolina is offering licensing opportunities for Blood-cytokine levels as adverse outcome predictors following biomaterial implant surgery
Background:
Despite the high number of patients undergoing reconstruction surgery with surgical mesh and the relatively high number of adverse outcomes, there are currently...
Published: 7/10/2026
|
Updated: 8/2/2022
|
Inventor(s): Melissa Moss, Mihyun Waugh, Nicholas Boltin, Lauren Wolf, Ronnie Horner, Matthew Hermes, Thomas Wheeler, Richard Goodwin
Keywords(s): anti-inflammatory biotech, anti-inflammatory pharma, biomaterial implant, Blood samples, cytokines, implant rejection, inflammation, pelvic organ prolapse, plasma, predictive outcome, principal component analysis, surgical mesh
Category(s): Health Sciences
|
|
Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16)
Reference #: 01544
The University of South Carolina is offering licensing opportunities for Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16)
Background:
DYT16 is a rare movement disorder, so the number of patients worldwide is small. However, Alzheimer's disease, Down syndrome are very prevalent and large numbers...
Published: 6/13/2024
|
Updated: 1/13/2022
|
Inventor(s): Rekha Patel
Keywords(s): anti-inflammatory pharma, dystonia, DYT16, inflammation, movement disorder, PACT, PKR
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
Immune CB1 Activation for Obesity Therapy
Reference #: 01478
The University of South Carolina is offering licensing opportunities for Immune CB1 activation for obesity therapy
Background:
The endocannabinoid system regulates various physiological processes such as inflammation and metabolism, and is comprised of cannabinoid receptors, CB1 and CB2, as well as their ligands called endocannabinoids....
Published: 6/11/2026
|
Updated: 5/7/2021
|
Inventor(s): Prakash Nagarkatti, Mitzi Nagarkatti, Kathryn Miranda
Keywords(s): anti-inflammatory pharma, cannabinoids, CB1, inflammation, metabolic syndrome, Obesity, weight loss
Category(s): Health Sciences, Biomedical and Life Sciences
|
|
Natural Compounds for Modulation of Cell Secretome Production and Composition
Reference #: 01421
The University of South Carolina is offering licensing opportunities for Natural Compounds for Modulation of Cell Secretome Production and Composition
Background:
Plants are the oldest source of natural compounds with medicinal and cosmetic properties explored by the world. 11% of the existed essential drugs used in modern human...
Published: 4/28/2026
|
Updated: 10/24/2019
|
Inventor(s): Ehsan Jabbarzadeh, Maria Yanez, Sara Eslambolchimoghadam
Keywords(s): anti-inflammatory, anti-inflammatory biotech, anti-inflammatory pharma, catalyzing stem cell secretome, cell-free therapy, chronic wound treatment, condition media, natural, Natural product, regenerative therapy
Category(s): Biomedical and Life Sciences, Health Sciences
|